Quickly verify claims by accessing the underlying experimental data and figures.
Press Enter ↵ to solve
Fuel Your Discoveries
"Biology gives you a brain. Life turns it into a mind."
- Jeffrey Eugenides
Quick Answer
Copied
Paper target
This review synthesizes evidence that adult-born neurons (especially hippocampal) could contribute to affective outcomes, while emphasizing that human proof is methodologically fragile (postmortem handling, marker specificity, and species differences).
Long Answer
The impact of adult neurogenesis on affective functions: of mice and men
Molecular Psychiatry review • Published 2024-03-18 • DOI: 10.1038/s41380-024-02504-w
Evidence scope: this page critiques the review’s claims using only the paper text you provided plus the cited studies whose metadata/numbers are included in your input.
1) What the review is actually claiming (scientific core)
Adult neurogenesis exists across mammals, and its kinetics vary by species/region; primate maturation is slower and adult rates can differ.
Immature/new neurons are proposed to matter for affect via hippocampal circuit remodelling (e.g., DG/CA3 computations, inhibition/sparsification, and behavioural links), but human causal proof is not established.
Regulators emphasized include stress/glucocorticoids, inflammation, and gut microbiota, which can converge on adult neurogenesis.
2) Visual evidence synthesis (grounded in the data/numbers you provided)
Because this input contains only a partial set of numeric results across cited papers, the figures below restrict themselves to numeric claims that were explicitly provided in your excerpt metadata.
Figure A — Adult hippocampal neurogenesis markers: Healthy aging vs Alzheimer’s disease (DCX+ immature neurons)
The review cites (and your input provides numbers from) Moreno-Jiménez et al. showing DCX+ immature dentate granule neurons are abundant in neurologically healthy controls but decline and exhibit impaired maturation in Alzheimer’s disease.
Important limitation: the provided excerpt does not include the full per-disease-stage DCX densities, so the plot uses only the explicit subject-count numbers to avoid inventing values.
Figure B — Methodological bottleneck: postmortem delay as a known confound for detecting “immature” markers
Your excerpt of Moreno-Jiménez et al. explicitly states postmortem delay ranges and outliers (2.5–10 hours for most samples; three specific samples with longer delays).
Skeptical interpretation: marker detectability for immature-neuron proxies can be sensitive to fixation/processing, and the review explicitly flags technical caveats as a reason for inconsistent human findings.
Why this matters: if “immature-neuron” proxies (e.g., DCX/PSA-NCAM) degrade or shift with processing, between-study disagreements can arise without a real biological difference.
3) Mechanistic plausibility vs causal sufficiency (tight skeptical separation)
3.1 What supports the “plausible” mechanism?
The review describes DG circuit remodeling consistent with a role in affect-related computation (e.g., synaptic competition, inhibitory gating, sparse firing effects), grounded in the mechanistic neurogenesis literature it cites.
It also links stress and immune activation to changes in neurogenesis and affective phenotypes (depression-like/sickness-like behaviors), presenting a gut–brain–immune bridge.
3.2 What prevents “causal sufficiency” in humans?
Marker/proxy ambiguity: the review stresses that DCX/PSA-NCAM-like signals can be decoupled from recent birth and can be affected by processing and antigen retrieval.
Design limitations: the review repeatedly notes difficulty establishing causality in humans (no direct, ethically feasible neurogenesis “knockout” or birthdating manipulations), so “adult neurogenesis exists” does not automatically imply “adult neurogenesis drives affect” in vivo.
Confounding by aging/disease/treatments: postmortem cohorts include variable health histories and causes of death, and disease and medication effects can change proliferation, survival, inflammation, and marker detectability.
Postmortem marker studies (e.g., DCX/PSA-NCAM), plus advanced transcriptomic approaches described; also primate kinetics.
Moderate (heterogeneous but converging on “immature neurons may persist,” not uniform agreement on magnitude).
Neurogenesis modulates hippocampal computation
Rodent circuit and synaptic studies (competition, inhibitory gating, sparsification).
Strong (mechanistic plausibility is supported in animals; generalization remains an inference).
Neurogenesis↔affective outcomes (causal human link)
Human imaging/neuropathology associations + treatment-related correlations; no direct neurogenesis-specific manipulation in humans.
Weak to moderate (promising but not decisive; confounding by disease, treatments, inflammation, and technical proxies is substantial).
5) Targeted critique: strong points and concrete blind spots
5.1 Strengths
Explicit attention to human-method confounds: postmortem interval, fixation, antigen retrieval, and marker proxy issues are called out, rather than ignored.
Mechanistic integration across domains: stress hormones, immune/inflammation pathways, and gut microbiome are presented as converging regulators rather than independent stories.
5.2 Blind spots / where the review could overreach (based on the provided text)
Proxy-to-causality leap risk: the review argues that adult neurogenesis could be an integrative process affecting affective outcomes, but it does not—and cannot—replace human causal tests.
Heterogeneity of “affective disorders”: the review notes diagnostic heterogeneity and the challenge of mapping DSM syndromes to animal testable dimensions, which implies that even a real neurogenesis role might be domain- or mechanism-specific.
Publication-bias/selection-bias sensitivity: because many endpoints are correlational and marker-dependent, the literature could preferentially report detectable neurogenesis patterns. This concern is consistent with the review’s discussion of technical reasons for conflicting reports.
6) What would most falsify the review’s central “neurogenesis matters for affect” thesis?
Human-specific falsification: demonstrate (using orthogonal methods controlling PMD/fixation/antigen retrieval) that the presence/maturation spectrum of immature DG neurons is not altered across age or disease and is not associated with affective phenotypes—i.e., that observed “immature” markers do not track meaningful biology. This is conceptually aligned with the review’s focus on methodological caveats.
Causal human falsification: show that affective improvements from interventions (or longitudinal state transitions) persist despite credible evidence that neurogenesis/maturation is unaltered; the review itself frames causal uncertainty as unresolved.
Author reviews you can open next
Feedback:
Updated: March 21, 2026
BGPT Paper Review
Study Novelty
70%
A broad, integrative review of adult neurogenesis and affective functions is established territory, but the paper’s novelty is its emphasis on translational tension plus convergence via stress/inflammation/gut–brain mechanisms and the “plural” neurogenesis framing (with human marker controversies highlighted).
Scientific Quality
80%
Quality is limited by the intrinsic constraints of a review (no new experiments; susceptibility to selection/weighting effects), but the manuscript text provided shows careful attention to methodological caveats in humans and distinguishes animal causal evidence from human causal uncertainty.
Study Generality
80%
The discussion connects a widely studied neurobiological process (adult neurogenesis) to a cross-cutting domain (affective dysfunction), with mechanistic bridges (immune/inflammation and microbiome) that generalize across many affect-relevant models—though species and marker issues remain central.
Study Usefulness
90%
The review is practically useful as a structured map of: (i) where evidence is strongest (animal circuitry), (ii) where it breaks (human measurement/causality), and (iii) which biological regulators (stress, inflammation, microbiome) are most often used to connect neurogenesis to affect.
Study Reproducibility
60%
Reproducibility is constrained not by experimental implementation (this is a review), but by the reproducibility of the underlying measurements it summarizes—especially human marker detectability affected by PMD/fixation/antigen retrieval.
Explanatory Depth
80%
The paper provides mechanistic depth on circuit-level DG roles and integrates environmental and immune regulators into a coherent explanatory framework, while still being cautious about what can and cannot be concluded causally in humans.
Converts the provided AD-vs-control subject counts and PMD range metadata into Plotly-ready arrays and generates labeled QC plots highlighting confound-sensitive variables.
Get emailed when your analysis is done!
We'll email you the results when your analysis is finished.
Hypothesis Graveyard
A simple “more DCX always means more antidepressant effect” model is unlikely because the review emphasizes marker limitations and the possibility that immature-like markers can arise or persist independent of recent birth, especially across species and processing conditions.
A “gut microbiome affects mood only through neurogenesis” framing is probably too strong; the review itself frames neurogenesis as one mediator within broader gut–brain–immune signaling, implying multiple parallel pathways to affective outcomes.
Quick Answer
Long Answer
Top Data Sources
ExportMCP
Analysis Wizard
Hypothesis Graveyard
Potential Experiments
Discussion
Fuel Your Discoveries
Ask a Follow-Up
Key Insight
Keep Exploring
